Clinical Software Tools
Radialogica supports patients and providers with software tools that enhance the quality and safety of radiotherapy treatment and promote consistency of care across delivery networks.
Our Products
SciMoCa™ leverages the power of Monte Carlo for independent dose calculation and plan QA. Developed in collaboration with Prof. Dr. Markus Alber and Scientific RT, SciMoCa combines the accuracy of Monte-Carlo dose calculations and the precision of custom beam models for robust dose verification and plan quality evaluation.
Accuracy – a best-in-class Monte Carlo dose calculation
engine with a prominent academic pedigree that delivers
validated accuracy with fast calculation times
Precision – custom beam models to maximize calculation
integrity with support for Varian, Elekta, Cyberknife,
TomoTherapy, Radixact, ZAP-X and Siemans delivery devices
Analysis – a comprehensive suite of dose analysis and
reporting tools along with workflow automation to
streamline plan review and approval
Deployment – integrates seamlessly within your IT infrastructure with no proprietary hardware required
- Photon and electron Monte Carlo dose calculation
- Machine-specific, generic, and golden beam data models
- Comparative plan quality metrics
- Comparative DVH
- 3D gamma analysis
- Image slice viewer
- Beam data table
- Plan approval and reporting
- Support for real-time online adaptive planning
fullAccess™ is a fully integrated radiotherapy data display, communication, and analysis platform that enables clinicians across the continuum of care to access, analyze, and share RT data. fullAccess supports flexible viewing of multi-modality diagnostic images and multi-vendor treatment plans, extraction, analysis and benchmarking of plan quality metrics, and sharing of RT data between facilities and caregivers for clinical collaboration.
View – Visualize images and treatment plans for all major
treatment modalities, delivery devices and planning systems
from a single application
Analyze – evaluate plan quality metrics with user-defined
templates and benchmark performance against historic results
Annotate – add clinical commentary in the plan that can be
reviewed and responded to by members of the treatment team
Package – bundle treatment plans, annotations, and file
attachments into a single file with an embedded RT viewer
Share – distribute radiotherapy treatment plans and other files inside and outside the clinic, including to patients and referral partners
- Plan review
- Remote review
- Peer review
- Plan quality benchmarking
- Case conference
- Referral partners
- Training and education
- Permanent and portable patient records
News & Information
Aarhus University Hospital Publishes Results of SciMoCa Software Comparison
Investigation quantifies the benefits of Monte Carlo dose computation and custom beam models for independent secondary dose calculation and patient-specific quality assurance. Research conducted by the Department of Oncology at Aarhus University Hospital in Denmark aimed to evidence the value of Monte Carlo dose calculation over analytical algorithms and the benefit of customized beam models […]
Clario expands oncology trial support through collaboration with Radialogica to enhance radiation therapy quality control
Solutions provide sponsors greater control and consistency when radiation therapy is part of the clinical trial protocol. Clario, a leading provider of endpoint data solutions to the clinical trials industry, has expanded its oncology trial support by collaborating with Radialogica to offer enhanced quality control for radiation therapy (RT). This new capability helps sponsors ensure […]
Radialogica to Support TRIBUTE Trial with Radiation Therapy Quality Assurance
Radialogica, a leading provider of radiation oncology quality management solutions, announced it has been selected by the Society of Interventional Oncology (SIO) to provide data collection, curation and analytics services for the TRIBUTE trial. TRIBUTE is a prospective, multi-center observational study evaluating patients with symptomatic, high-risk bone metastases treated with percutaneous ablation and palliative radiation […]